Cadre Holdings (CDRE) director receives 17,393 stock options at $28.75
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Cadre Holdings director William G. Quigley III received a grant of stock options for 17,393 shares of common stock at an exercise price of $28.75 per share. The options were granted under Cadre’s 2021 Stock Incentive Plan as equity-based compensation.
These options vest in four installments: options to purchase 4,349 shares vest and become exercisable on June 30, 2026, and options to purchase 4,348 shares vest and become exercisable on each of September 30, 2026, December 31, 2026, and March 31, 2027. Any unexercised options expire on June 16, 2036.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
QUIGLEY WILLIAM G III
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to purchase) | 17,393 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to purchase) — 17,393 shares (Direct, null)
Footnotes (1)
- [object Object]
Key Figures
Options granted: 17,393 options
Exercise price: $28.75 per share
First vesting tranche: 4,349 options
+3 more
6 metrics
Options granted
17,393 options
Grant of stock options to director on June 16, 2026
Exercise price
$28.75 per share
Stock option exercise price for Cadre common stock
First vesting tranche
4,349 options
Vest and become exercisable on June 30, 2026
Subsequent vesting tranches
4,348 options each
Vest on Sept 30, 2026; Dec 31, 2026; Mar 31, 2027
Expiration date
June 16, 2036
Option expiration if unexercised
Options held after transaction
17,393 derivatives
Total derivative securities following this grant
Key Terms
Stock Option (right to purchase), 2021 Stock Incentive Plan, vest and become exercisable, Common Stock, +1 more
5 terms
Stock Option (right to purchase) financial
"security_title: "Stock Option (right to purchase)""
2021 Stock Incentive Plan financial
"was granted under the Issuer's 2021 Stock Incentive Plan"
vest and become exercisable financial
"will vest and become exercisable on June 30, 2026"
Common Stock financial
"underlying_security_title: "Common Stock""
Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.
Grant, award, or other acquisition financial
"transaction_code_description: "Grant, award, or other acquisition""
FAQ
What insider transaction did Cadre Holdings (CDRE) report for William G. Quigley III?
Cadre Holdings reported that director William G. Quigley III received a grant of stock options for 17,393 shares of common stock at an exercise price of $28.75. This grant is equity compensation under the company’s 2021 Stock Incentive Plan, not an open-market purchase or sale.
What is the vesting schedule of the new Cadre Holdings (CDRE) stock options?
The 17,393 options vest in four tranches: 4,349 options on June 30, 2026, and 4,348 options on each of September 30, 2026, December 31, 2026, and March 31, 2027. Each tranche becomes exercisable as it vests, subject to continued service or plan terms.
What is the exercise price and expiration date of the Cadre Holdings (CDRE) options granted?
The options granted to William G. Quigley III have an exercise price of $28.75 per share and an expiration date of June 16, 2036. They can be exercised only after vesting dates and before expiration, following the company’s 2021 Stock Incentive Plan rules.
How many Cadre Holdings (CDRE) derivative securities does William G. Quigley III hold after this grant?
Following this grant, William G. Quigley III holds 17,393 stock options linked to Cadre Holdings common stock. Each option represents the right to purchase one share at $28.75, subject to the specified vesting schedule and the June 16, 2036 expiration.